[Development of anti-influenza drug]

Bing Du Xue Bao. 2011 Sep;27(5):475-80.
[Article in Chinese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • DNA-Directed RNA Polymerases / antagonists & inhibitors
  • Drug Discovery*
  • Hemagglutinin Glycoproteins, Influenza Virus / chemistry
  • Hemagglutinin Glycoproteins, Influenza Virus / metabolism
  • Humans
  • Influenza A virus / drug effects*
  • Influenza A virus / genetics
  • Influenza A virus / metabolism
  • Influenza, Human / drug therapy*
  • Molecular Targeted Therapy
  • Neuraminidase / antagonists & inhibitors
  • Nucleocapsid Proteins
  • RNA-Binding Proteins / antagonists & inhibitors
  • Signal Transduction / drug effects
  • Viral Core Proteins / antagonists & inhibitors
  • Viral Matrix Proteins / antagonists & inhibitors

Substances

  • Antiviral Agents
  • Hemagglutinin Glycoproteins, Influenza Virus
  • M2 protein, Influenza A virus
  • NP protein, Influenza A virus
  • Nucleocapsid Proteins
  • RNA-Binding Proteins
  • Viral Core Proteins
  • Viral Matrix Proteins
  • DNA-Directed RNA Polymerases
  • Neuraminidase